Overall Technical outlook

Price Summary

Regeneron Pharmaceuticals, Inc.'s stock saw a -2.61% collapse, showcasing an unimpressive market day.
Regeneron Pharmaceuticals, Inc.'s stock started trading at 751.37 on 2026-04-28, climbed to 753.88, fell to 730.9, and closed -2.61% down at 731.77, with 523560 shares traded.
During the 52-week span, the stock hit a high of 812.27 and a low of 483.07.
The future price of REGN is anticipated to range from 730.0 to 1057.0, with an expected mean price of 875.4489, according to the recommendations of 28 analysts.

Technicals

Support and Resistance: The price of 731.77 is supported at 692.58 and capped by resistance at 733.78. These levels mark key points for Regeneron Pharmaceuticals, Inc. where the price could find stability, with 692.58 as a floor and 733.78 as a ceiling.
REGN supportResistance 9345e3
Support/Resistance for REGN


Aroon: The Aroon indicator shows a continuation of the bearish trend, with Aroon Down holding steady at the 100 level. This ongoing downward pressure requires further exploration with additional indicators to understand its broader implications.
REGN aroon 9345e3
Aroon chart for Regeneron Pharmaceuticals, Inc.


Bol. Bands: The price has recently crossed below the lower Bollinger Band, suggesting the market may be in an oversold condition. This move reflects strong selling pressure that has pushed prices below a key level. While this breach could indicate a continuation of the current downtrend for Regeneron Pharmaceuticals, Inc., it might also serve as a signal for a potential reversal if the market finds support at these lower levels.
REGN bbands 9345e3
Bolinger Bands chart for Regeneron Pharmaceuticals, Inc.


Parabolic SAR: The PSAR has just shifted from bullish to bearish, hinting at a potential market decline. If this reversal is supported by other trends, it could be a very bearish signal for REGN. Investors should be vigilant and seek further confirmation before taking action.
REGN psar 9345e3
Parabolic Stop and Reverse chart for Regeneron Pharmaceuticals, Inc.


Stochastic: The current state of the STOCHASTIC is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
REGN stoch 9345e3
Stochastic chart for Regeneron Pharmaceuticals, Inc.


Tripple Moving Agerage: The current reading of the Tripple MOVING AVG is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
REGN trippleSMA 9345e3
Tripple SMA chart for Regeneron Pharmaceuticals, Inc.


A thorough analysis of a company involves looking at both its fundamentals and technical data. The fundamentals, including revenue, profitability, and management quality, offer insight into the company's long-term value. Additionally, understanding the broader industry context, such as market competition and regulatory challenges, helps to better interpret the company's stock performance. By combining both fundamental and technical analysis, you can derive more meaningful inferences about the company's future prospects.